# Peyronie's Disease Treatment Protocol

> **NCT02072018** · PHASE1 · COMPLETED · sponsor: **Hybrid Medical** · enrollment: 22 (actual)

## Conditions studied

- Peyronie's Disease

## Interventions

- **DRUG:** H-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02072018
- **Lead sponsor:** Hybrid Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072018, "Peyronie's Disease Treatment Protocol". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02072018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*